MeSH Browser

MeSH Heading: Cysteamine
Tree Number(s): D02.092.471.562.369; D02.886.489.472.369
Unique ID: D003543
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D003543
Annotation: do not confuse with CYSTAMINE
Scope Note: A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.
Entry Term(s): 2-Aminoethanethiol; Becaptan; Cystagon; Cysteamine Bitartrate; Cysteamine Dihydrochloride; Cysteamine Hydrobromide; Cysteamine Hydrochloride; Cysteamine Maleate (1:1); Cysteamine Tartrate; Cysteamine Tartrate (1:1); Cysteamine Tosylate; Cysteamine, 35S-Labeled; Cysteinamine; Mercamine; Mercaptamine; Mercaptoethylamine; beta-Mercaptoethylamine
Pharm Action: Cystine Depleting Agents
Registry Number: 5UX2SD1KE2
Related Numbers: 156-57-0; 16904-32-8; 3037-04-5; 42954-15-4; 55707-28-3; 60-23-1; 93965-19-6; IF1B771SVB; QO84GZ3TST
CAS Type 1 Name: Ethanethiol, 2-amino-
Public MeSH Note: CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66
Online Note: use MERCAPTOETHYLAMINES to search CYSTEINAMINE 1966
History Note: CYSTEINAMINE was see under MERCAPTOETHYLAMINES 1963-66
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2014/06/12

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0005535
Registry Number: 5UX2SD1KE2
Related Numbers: 156-57-0; 16904-32-8; 3037-04-5; 42954-15-4; 55707-28-3; 60-23-1; 93965-19-6; IF1B771SVB; QO84GZ3TST
Scope Note: A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.
Terms: Cysteamine Preferred Term
Term UI T010282
Date01/01/1999
LexicalTag NON
ThesaurusID; beta-Mercaptoethylamine
Term UI T010281
Date06/29/1992
LexicalTag NON
ThesaurusID NLM (1993); Mercaptoethylamine
Term UI T010286
Date09/19/1984
LexicalTag NON
ThesaurusID UNK (19XX); Mercamine
Term UI T010284
Date08/01/1980
LexicalTag NON
ThesaurusID UNK (19XX); Mercaptamine
Term UI T010285
Date07/17/1975
LexicalTag NON
ThesaurusID; 2-Aminoethanethiol
Term UI T010279
Date08/25/1980
LexicalTag NON
ThesaurusID; Cysteinamine
Term UI T010283
Date03/29/1974
LexicalTag NON
ThesaurusID UNK (19XX)

Cysteamine MeSH Descriptor Data 2023